Insmed
INSM
#739
Rank
S$43.22 B
Marketcap
S$202.68
Share price
-2.88%
Change (1 day)
89.62%
Change (1 year)

Market capitalization of Insmed (INSM)

Market cap: S$43.22 Billion

As of February 2026 Insmed has a market cap of S$43.22 Billion. This makes Insmed the world's 739th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insmed from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026S$43.22 B-11.25%
2025S$48.70 B187.74%
2024S$16.92 B189.1%
2023S$5.85 B61.36%
2022S$3.62 B-16.76%
2021S$4.35 B-2.83%
2020S$4.48 B55.38%
2019S$2.88 B108.37%
2018S$1.38 B-56.62%
2017S$3.19 B169.58%
2016S$1.18 B-25.34%
2015S$1.58 B55.88%
2014S$1.01 B20.77%
2013S$0.84 B227.23%
2012S$0.25 B162.63%
2011S$98.08 M-22.88%
2010S$0.12 B-9.63%
2009S$0.14 B72.12%
2008S$81.77 M-43.49%
2007S$0.14 B5.84%
2006S$0.13 B-37.34%
2005S$0.21 B35.49%
2004S$0.16 B-16.87%
2003S$0.19 B649.34%
2002S$25.85 M-88.9%
2001S$0.23 B18.1%
2000S$0.19 B

End of Day market cap according to different sources

On Feb 22nd, 2026 the market cap of Insmed was reported to be:

S$44.50 Billion
by Nasdaq info icon info icon
S$44.50 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
S$403.26 B 832.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
S$235.21 B 444.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$155.77 B 260.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$2.40 B-94.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S$0.95 B-97.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
S$2.06 B-95.22%๐Ÿ‡บ๐Ÿ‡ธ USA